Author

Anna Herland

Primary ORCID profile (0000-0002-5002-2537 · 3 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Anna HerlandiD3 papers · Science for Life Laboratory

Biology Disciplines

Click to filter author papers

Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Organism:human· 1 Approach:microscopy & imaging analysis· 1

Frequent Co-Authors

Alexander Watters· 1 shared Donald E. IngberiD· 1 shared Edward A. FitzGerald· 1 shared Eric Shusta· 1 shared Hannah W. Song· 1 shared Heather J. McCrea· 1 shared Henry Sanchez· 1 shared Liliana Christova Goumnerova· 1 shared

Activity by Year

2018-2018 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

Alexander Watters

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Hypoxia-enhanced Blood-Brain Barrier Chip recapitulates human barrier function, drug penetration, and antibody shuttling properties

Tae-Eun Park, Nur Mustafaoglu, Anna Herland, Ryan Hasselkus, Robert Mannix, Edward A. FitzGerald, Rachelle Prantil-Baun, Alexander Watters, Olivier Henry, Maximilian Benz, Henry Sanchez, Heather J. McCrea, Liliana Christova Goumnerova, Hannah W. Song, Sean P. Palecek, , Donald E. Ingber

This paper develops a BBB chip that maintains high barrier function for a week, enabling better drug and antibody testing.

bioRxiv · Nov 29, 2018 · PreprintBioengineering